$EVH
Evolent Health, Inc. Stock $evh

$evh Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000162890817000044 Filed on August 07, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$107.1M	$56.52M
YoY Change	89.45%	442.71%
Cost Of Revenue	$68.00M	$32.80M
YoY Change	107.32%	315.19%
Gross Profit	$39.10M	$23.70M
YoY Change	64.98%	848.0%
Gross Profit Margin	36.52%	41.93%
Selling, General & Admin	$51.09M	$32.76M
YoY Change	55.97%	150.39%
% of Gross Profit	130.66%	138.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.900M	$800.0K
YoY Change	137.5%	300.0%
% of Gross Profit	4.86%	3.38%
Operating Expenses	$126.2M	$69.15M
YoY Change	82.49%	214.98%
Operating Profit	-$19.12M	-$12.63M
YoY Change	51.37%	9.45%
Interest Expense	$947.0K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$3.000K	$1.000K
YoY Change	200.0%
Pretax Income	-$20.40M	-$12.37M
YoY Change	64.9%	-103.21%
Income Tax	-$700.0K	-$400.0K
% Of Pretax Income
Net Earnings	-$16.91M	-$8.387M
YoY Change	101.56%	-102.33%
Net Earnings / Revenue	-15.79%	-14.84%
Basic Earnings Per Share	-$0.28	-$0.20
Diluted Earnings Per Share	-$0.28	-$0.20
COMMON SHARES
Basic Shares Outstanding	59.48M shares	42.59M shares
Diluted Shares Outstanding	59.48M shares	42.59M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$124.0M	$132.7M
YoY Change	-6.56%	-39.52%
Cash & Equivalents	$99.98M	$105.1M
Short-Term Investments	$24.00M	$27.60M
Other Short-Term Assets	$22.90M	$7.500M
YoY Change	205.33%	-9.64%
Inventory
Prepaid Expenses
Receivables	$45.80M	$30.34M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$192.6M	$170.6M
YoY Change	12.94%	-32.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.19M	$18.47M
YoY Change	117.64%
Goodwill	$628.7M	$459.7M
YoY Change	36.75%	-24.5%
Intangibles	$254.5M	$165.4M
YoY Change	53.81%	-2.11%
Long-Term Investments	$1.100M	$27.20M
YoY Change	-95.96%
Other Assets	$9.483M	$9.859M
YoY Change	-3.81%	6429.14%
Total Long-Term Assets	$945.7M	$682.2M
YoY Change	38.62%	-13.44%
TOTAL ASSETS
Total Short-Term Assets	$192.6M	$170.6M
Total Long-Term Assets	$945.7M	$682.2M
Total Assets	$1.138B	$852.8M
YoY Change	33.48%	-17.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.28M	$12.38M
YoY Change	112.36%	-8.54%
Accrued Expenses	$25.92M	$8.513M
YoY Change	204.46%	-57.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$101.8M	$56.73M
YoY Change	79.39%	-6.71%
LONG-TERM LIABILITIES
Long-Term Debt	$120.9M	$0.00
YoY Change
Other Long-Term Liabilities	$10.02M	$7.972M
YoY Change	25.74%
Total Long-Term Liabilities	$10.02M	$7.972M
YoY Change	25.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$101.8M	$56.73M
Total Long-Term Liabilities	$10.02M	$7.972M
Total Liabilities	$243.9M	$84.66M
YoY Change	188.11%	-7.11%
SHAREHOLDERS EQUITY
Retained Earnings	$111.7M	$175.2M
YoY Change	-36.26%	-45.71%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$859.8M	$537.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.138B	$852.8M
YoY Change	33.48%	-17.99%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$16.91M	-$8.387M
YoY Change	101.56%	-102.33%
Depreciation, Depletion And Amortization	$1.900M	$800.0K
YoY Change	137.5%	300.0%
Cash From Operating Activities	-$3.040M	-$1.120M
YoY Change	171.43%	-80.72%
INVESTING ACTIVITIES
Capital Expenditures	-$6.450M	-$3.910M
YoY Change	64.96%	283.33%
Acquisitions
YoY Change
Other Investing Activities	$3.170M	-$910.0K
YoY Change	-448.35%	-105.33%
Cash From Investing Activities	-$3.280M	-$4.810M
YoY Change	-31.81%	-129.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.98M	-230.0K
YoY Change	4673.91%	-100.11%
NET CHANGE
Cash From Operating Activities	-3.040M	-1.120M
Cash From Investing Activities	-3.280M	-4.810M
Cash From Financing Activities	-10.98M	-230.0K
Net Change In Cash	-17.30M	-6.160M
YoY Change	180.84%	-102.81%
FREE CASH FLOW
Cash From Operating Activities	-$3.040M	-$1.120M
Capital Expenditures	-$6.450M	-$3.910M
Free Cash Flow	$3.410M	$2.790M
YoY Change	22.22%	-158.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10464000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38408000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	456000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5200000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001628908
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Evolent Health, Inc.
CY2016	evh	Abandonment Amortization AbandonmentAmortization	360000	USD
	evh	Abandonment Amortization AbandonmentAmortization	765000	USD
CY2016	evh	Adjustmentsto Additional Paidin Capital Adjustmentfrom Adoptionof New Accounting Principle AdjustmentstoAdditionalPaidinCapitalAdjustmentfromAdoptionofNewAccountingPrinciple	0	USD
CY2016Q2	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-3005000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2200000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
	evh	Business Acquisition Pro Forma Net Income Loss Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossAttributabletoNoncontrollingInterest	-49012000	USD
CY2016Q2	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-11616000	USD
	evh	Business Acquisition Pro Forma Net Income Loss Including Portion Attributableto Noncontrolling Interest BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributabletoNoncontrollingInterest	-189236000	USD
CY2017Q2	evh	Cash Fdic Insured Amount Percentage CashFDICInsuredAmountPercentage	0.397
CY2017Q2	evh	Cash Held In Money Market Funds Percentage CashHeldInMoneyMarketFundsPercentage	0.603
CY2016Q2	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	32779000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	61390000	USD
CY2017Q2	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	67994000	USD
	evh	Costof Goodsand Services Sold Excluding Depreciationand Amortization CostofGoodsandServicesSoldExcludingDepreciationandAmortization	135523000	USD
CY2016	evh	Fair Value Inputs Longterm Revenue Growth Rate Theoretical Recurring Revenue FairValueInputsLongtermRevenueGrowthRateTheoreticalRecurringRevenue	1000000	USD
	evh	Fair Value Inputs Longterm Revenue Growth Rate Theoretical Recurring Revenue FairValueInputsLongtermRevenueGrowthRateTheoreticalRecurringRevenue	1000000	USD
CY2016Q2	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	100000	USD
CY2017Q2	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	200000	USD
	evh	Income Lossfrom Equity Method Investments Services Agreement IncomeLossfromEquityMethodInvestmentsServicesAgreement	300000	USD
CY2016	evh	Liabilities Subject To Compromise Impact Of Lease Termination LiabilitiesSubjectToCompromiseImpactOfLeaseTermination	0	USD
	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	0	USD
	evh	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Measurement Period Adjustment NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationMeasurementPeriodAdjustment	2078000	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	10534000	USD
	evh	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issued Value NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue	0	USD
CY2016Q4	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	4507000	USD
CY2017Q2	evh	Prepaid Expenseand Other Assets Current Related Parties PrepaidExpenseandOtherAssetsCurrentRelatedParties	53000	USD
CY2016	evh	Risk Adjusted Recurring Revenue Compound Annual Growth Rate Period RiskAdjustedRecurringRevenueCompoundAnnualGrowthRatePeriod	P5Y
	evh	Risk Adjusted Recurring Revenue Compound Annual Growth Rate Period RiskAdjustedRecurringRevenueCompoundAnnualGrowthRatePeriod	P5Y
CY2016	evh	Stock Issued During Period Conversionof Convertible Securities Tax Impact StockIssuedDuringPeriodConversionofConvertibleSecuritiesTaxImpact	1606000	USD
	evh	Stock Issued During Period Conversionof Convertible Securities Tax Impact StockIssuedDuringPeriodConversionofConvertibleSecuritiesTaxImpact	11426000	USD
CY2016	evh	Stock Issued During Period Value Acceleration Of Equity Awards As Part Of Business Combination StockIssuedDuringPeriodValueAccelerationOfEquityAwardsAsPartOfBusinessCombination	3899000	USD
CY2016	evh	Stock Issued During Period Value Acquisitions Tax Effect StockIssuedDuringPeriodValueAcquisitionsTaxEffect	1427000	USD
CY2017Q2	evh	Tax Receivables Agreement Percentof Tax Savingstobe Paid TaxReceivablesAgreementPercentofTaxSavingstobePaid	0.85
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	43892000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	26280000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	13480000	USD
CY2017Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	7814000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40635000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45804000	USD
	us-gaap	Accretion Expense AccretionExpense	0	USD
	us-gaap	Accretion Expense AccretionExpense	105000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29160000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25919000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5236000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8945000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	555250000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	747385000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16147000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10464000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4709000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9045000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5360000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9700000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19036000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18514000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17686000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20800000	shares
CY2016Q4	us-gaap	Assets Assets	1199839000	USD
CY2017Q2	us-gaap	Assets Assets	1138352000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	264966000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	192620000	USD
CY2016Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.17
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-2.80
CY2016Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.17
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-2.80
CY2016Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-8611000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-140224000	USD
CY2016Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	88971000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	170297000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	200000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	98000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	291000	USD
CY2016Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	300000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	500000	USD
CY2017Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	900000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1600000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145726000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105138000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134563000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99975000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-40588000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-34588000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	113944000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	168883000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	196000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1360000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-280000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20481000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	27774000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	20846000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	11184000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	800000	USD
	us-gaap	Depreciation Depreciation	1500000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	1900000	USD
	us-gaap	Depreciation Depreciation	3700000	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3612000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6983000	USD
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6904000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13519000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6983000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13519000	USD
CY2016Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	8258000	USD
CY2017Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	4204000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3211000	USD
CY2017Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1284000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.09
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.030
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.034
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21787000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-200000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	7750000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7750000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7750000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8300000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8300000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8500000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18400000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28060000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	277323000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	282520000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	258923000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	254460000	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	496000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	608903000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	626569000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	628653000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	178266000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2016Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2016Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	160600000	USD
CY2017Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	2084000	USD
CY2016Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	44341000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	197000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	35000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	44503000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	24125000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	44341000	USD
CY2017Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1081000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	24027000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-187169000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	44503000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12370000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20398000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43143000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14000	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1077000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-371000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1359000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-700000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-295000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2975000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2514000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9956000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5247000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2524000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3621000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4013000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6719000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4934000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-16630000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	91000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4495000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	429000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1412000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1194000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-3200000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	258923000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	254460000	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	169000000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	947000	USD
	us-gaap	Interest Expense InterestExpense	1901000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	272000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	551000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	218000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	403000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	2159000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	287725000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	243903000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1199839000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1138352000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	131941000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	101760000	USD
CY2015Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
CY2016Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	6100000	USD
CY2017Q2	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	4839000	USD
CY2016	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	6460000	USD
	us-gaap	Liabilities Subject To Compromise Expense Reversal Of Expense For Liabilities LiabilitiesSubjectToCompromiseExpenseReversalOfExpenseForLiabilities	0	USD
CY2016Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	46130000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	87465000	USD
CY2017Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	101710000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	197714000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120283000	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	120935000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	209588000	USD
CY2017Q2	us-gaap	Minority Interest MinorityInterest	34680000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-204000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2385000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18466000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7739000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21918000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44712000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8387000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-131127000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-16905000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34918000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3612000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-54683000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2793000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7930000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8387000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-131127000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16905000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34918000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8387000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-131127000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16905000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34918000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	69147000	USD
	us-gaap	Operating Expenses OperatingExpenses	293675000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	126188000	USD
	us-gaap	Operating Expenses OperatingExpenses	253883000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-12629000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-187708000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-19117000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-40573000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1100000	USD
CY2017Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2400000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10043000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9483000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14655000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10024000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-276000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-291000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	USD
CY2017Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1000000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1300000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	318000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1175000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	14500000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3241000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7260000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12430000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11011000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12556000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2100000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	20210000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	114000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3560000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-11999000	USD
	us-gaap	Profit Loss ProfitLoss	-185810000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-226778000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-19698000	USD
	us-gaap	Profit Loss ProfitLoss	-42848000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36415000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49139000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31179000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40194000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40416000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	22119000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1050000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3711000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4950000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8150000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	34416000	USD
CY2017Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	10258000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	6000000	USD
CY2017Q2	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	11861000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	146617000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	111699000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	56518000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	105967000	USD
CY2017Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	107071000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	213310000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32756000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64702000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	51090000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104641000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9045000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10464000	USD
CY2015Q3	us-gaap	Share Price SharePrice	19.51
CY2015Q4	us-gaap	Share Price SharePrice	14.73
CY2016Q1	us-gaap	Share Price SharePrice	10.33
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	44341000	USD
CY2017Q2	us-gaap	Short Term Investments ShortTermInvestments	24027000	USD
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	177782000	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2193000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-1175000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1259000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3560000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-908000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	702526000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	859769000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	934579000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	912114000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	894449000	USD
CY2016Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	10388000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	18502000	USD
CY2017Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	5361000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	15596000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42594000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42390000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59478000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56057000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42594000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59478000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56057000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42390000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Estimates and Assumptions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates. In the accompanying consolidated financial statements, estimates are used for, but not limited to, the valuation of assets, liabilities, consideration related to business combinations and asset acquisitions, revenue recognition including discounts and credits, estimated selling prices for deliverables in multiple element arrangements, contingent payments, allowance for doubtful accounts, depreciable lives of assets, impairment of long lived assets (including equity method investments), stock-based compensation, deferred income taxes and valuation allowance, contingent liabilities, valuation of intangible assets (including goodwill) and the useful lives of intangible assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

Files In Submission

Name	View Source	Status
0001628908-17-000044-index-headers.html	Edgar Link	pending
0001628908-17-000044-index.html	Edgar Link	pending
0001628908-17-000044.txt	Edgar Link	pending
0001628908-17-000044-xbrl.zip	Edgar Link	pending
a063017exhibit311.htm	Edgar Link	pending
a063017exhibit312.htm	Edgar Link	pending
a063017exhibit321.htm	Edgar Link	pending
a063017exhibit322.htm	Edgar Link	pending
a63017exhibit101.htm	Edgar Link	pending
evh-20170630.xml	Edgar Link	completed
evh-20170630.xsd	Edgar Link	pending
evh-20170630_cal.xml	Edgar Link	unprocessable
evh-20170630_def.xml	Edgar Link	unprocessable
evh-20170630_lab.xml	Edgar Link	unprocessable
evh-20170630_pre.xml	Edgar Link	unprocessable
evh06301710-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVH
Evolent Health, Inc. Stock $evh

2017 Q2 Form 10-Q Financial Statement

#000162890817000044 Filed on August 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH Evolent Health, Inc. Stock $evh

2017 Q2 Form 10-Q Financial Statement

#000162890817000044 Filed on August 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVH
Evolent Health, Inc. Stock $evh